We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-5.01%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$380M
AUM Growth
-$34.7M
Cap. Flow
+$1.1M
Cap. Flow %
0.29%
Top 10 Hldgs %
55.07%
Holding
91
New
23
Increased
22
Reduced
16
Closed
28

Top Buys

Rank Stock Value
1
OFIX icon
Orthofix Medical
OFIX
+$13.4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$13.1M
3
CNC icon
Centene
CNC
+$12.1M
4
MCK icon
McKesson
MCK
+$7.93M
5
AVTR icon
Avantor
AVTR
+$6.38M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$21.3M
2
COR icon
Cencora
COR
+$15.3M
3
XRAY icon
Dentsply Sirona
XRAY
+$9.62M
4
BDX icon
Becton Dickinson
BDX
+$8.66M
5
SIBN icon
SI-BONE Inc
SIBN
+$7.34M

Sector Composition

Rank Sector Weight
1 Healthcare 70.45%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NRIX icon
76
Nurix Therapeutics
NRIX
$2.65B
– –
-43,542
Closed -$1.26M
ACH
77
Accendra Health
ACH
$214M
– –
-22,489
Closed -$978K
PODD icon
78
Insulet
PODD
$9.79B
– –
-6,394
Closed -$1.7M
RVTY icon
79
Revvity
RVTY
$12.8B
– –
-29,543
Closed -$5.94M
SNY icon
80
Sanofi
SNY
$104B
– –
-424,490
Closed -$21.3M
SPRY icon
81
ARS Pharmaceuticals
SPRY
$612M
– –
-84,295
Closed -$561K
SRPT icon
82
Sarepta Therapeutics
SRPT
$1.77B
– –
-33,191
Closed -$2.99M
TMCI icon
83
Treace Medical Concepts
TMCI
$309M
– –
-57,175
Closed -$1.07M
VCYT icon
84
Veracyte
VCYT
$3.8B
– –
-87,343
Closed -$3.6M
XRAY icon
85
Dentsply Sirona
XRAY
$2.43B
– –
-172,384
Closed -$9.62M
RCM
86
DELISTED
R1 RCM Inc. Common Stock
RCM
– –
-205,400
Closed -$5.24M
HGEN
87
DELISTED
HUMANIGEN, INC.
HGEN
– –
-154,613
Closed -$575K
OCDX
88
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
– –
-245,484
Closed -$5.25M
ZGNX
89
DELISTED
Zogenix, Inc.
ZGNX
– –
-160,640
Closed -$2.61M
1 2 3
4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Endurant Capital Management held 91 positions worth $380M, down 8.4% from $414M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Endurant Capital Management's Q1 2022 filing shows 23 new, 22 increased, 16 reduced and 28 closed positions. Its largest new stake was Bristol-Myers Squibb: 194,684 shares worth $14.2M. The largest sale was Sanofi, an estimated $21.3M.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, down from 72% a quarter earlier, followed by Industrials.

  • Endurant Capital Management's largest Q1 2022 buy was Bristol-Myers Squibb: 194,684 shares worth $14.2M.
  • Endurant Capital Management added most to Orthofix Medical in Q1 2022, an estimated $13.4M increase.
  • Endurant Capital Management's biggest Q1 2022 reduction was SI-BONE Inc, cutting an estimated $7.34M.
  • Endurant Capital Management fully exited Sanofi in Q1 2022, selling an estimated $21.3M.
  • Endurant Capital Management's ten largest holdings make up 55% of its $380M portfolio in Q1 2022.
  • Endurant Capital Management opened 23 new positions and closed 28 in Q1 2022.
  • Endurant Capital Management's portfolio value fell 8.4% quarter-over-quarter to $380M.

Based on Endurant Capital Management's 13F filing for Q1 2022, filed 16 May 2022.